IL23A and psoriasis: IL‐23 has been demonstrated as a key master cytokine that promotes T helper 17 (Th17) cell survival and proliferation, and targeting the IL‐23p19 subunit with a monoclonal antibody results in the clinical improvement in psoriasis (Zheng et al, 2007; Kopp et al, 2015).